Paradigm Biocapital Advisors LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$2.3T
Holdings
28
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 5,269,433 | $402.1B | 17.17% | |
| 2 | ACLXARCELLX INC | 4,649,016 | $306.1B | 13.07% | |
| 3 | MRUSMERUS N V | 4,281,954 | $225.2B | 9.62% | |
| 4 | RVMDREVOLUTION MEDICINES INC | 6,093,291 | $224.2B | 9.57% | |
| 5 | TARSTARSUS PHARMACEUTICALS INC | 2,976,099 | $120.6B | 5.15% | |
| 6 | PCVXVAXCYTE INC | 3,372,837 | $109.7B | 4.68% | |
| 7 | ONCBEONE MEDICINES LTD | 347,787 | $84.2B | 3.59% | |
| 8 | EWTXEDGEWISE THERAPEUTICS INC | 6,142,344 | $80.5B | 3.44% | |
| 9 | COGTCOGENT BIOSCIENCES INC | 10,352,449 | $74.3B | 3.17% | |
| 10 | JANXJANUX THERAPEUTICS INC | 2,920,258 | $67.5B | 2.88% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS IN | 2,343,553 | $67.4B | 2.88% | |
| 12 | IRONDISC MEDICINE INC | 1,210,971 | $64.1B | 2.74% | |
| 13 | SRRKSCHOLAR ROCK HLDG CORP | 1,600,554 | $56.7B | 2.42% | |
| 14 | LENZLENZ THERAPEUTICS INC | 1,717,066 | $50.3B | 2.15% | |
| 15 | BBIOBRIDGEBIO PHARMA INC | 965,764 | $41.7B | 1.78% | |
| 16 | APGEAPOGEE THERAPEUTICS INC | 958,630 | $41.6B | 1.78% | |
| 17 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 878,323 | $41.5B | 1.77% | |
| 18 | ALKSALKERMES PLC | 1,375,569 | $39.4B | 1.68% | |
| 19 | VRDNVIRIDIAN THERAPEUTICS INC | 2,741,576 | $38.3B | 1.64% | |
| 20 | AGIOAGIOS PHARMACEUTICALS INC | 1,142,511 | $38.0B | 1.62% | |
| 21 | OCULOCULAR THERAPEUTIX INC | 3,420,340 | $31.7B | 1.36% | |
| 22 | OLMAOLEMA PHARMACEUTICALS INC | 6,764,172 | $28.8B | 1.23% | |
| 23 | SYRESPYRE THERAPEUTICS INC | 1,870,445 | $28.0B | 1.20% | |
| 24 | YMABUSDY-MABS THERAPEUTICS INC | 4,236,346 | $19.1B | 0.82% | |
| 25 | PHVSPHARVARIS N V | 1,062,911 | $18.7B | 0.80% | |
| 26 | IMTXIMMATICS N.V | 3,144,157 | $16.9B | 0.72% | |
| 27 | ERASERASCA INC | 11,907,182 | $15.1B | 0.65% | |
| 28 | CBIOCRESCENT BIOPHARMA INC. | 642,721 | $10.4B | 0.44% |